BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dong M, Zheng G, Gao F, Li M, Zhong C. Three-Carbon Linked Dihydroartemisinin-Isatin Hybrids: Design, Synthesis and Their Antiproliferative Anticancer Activity. Front Pharmacol 2022;13:834317. [PMID: 35153798 DOI: 10.3389/fphar.2022.834317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu Z, Zhang X, Liu J, Zhao S, Liu J, Zhou W. Design, Synthesis, and Biological Evaluation of Novel Amyl Ester Tethered Dihydroartemisinin-Isatin Hybrids as Potent Anti-Breast Cancer Agents. Chem Biodivers 2023;20:e202201257. [PMID: 36808231 DOI: 10.1002/cbdv.202201257] [Reference Citation Analysis]
2 Zhao S, Zhang X, Tang M, Liu X, Deng J, Zhou W, Xu Z. Design, synthesis and anti-breast cancer properties of butyric ester tethered dihydroartemisinin-isatin hybrids. Med Chem Res 2023;32:705-12. [PMID: 36816432 DOI: 10.1007/s00044-023-03030-0] [Reference Citation Analysis]
3 Wang R, Zhang Q, Chen M. Artemisinin‐isatin hybrids tethered via ethylene linker and their anti‐lung cancer activity. Archiv der Pharmazie 2022. [DOI: 10.1002/ardp.202200563] [Reference Citation Analysis]
4 Yao Y, Wang H, Xu J, Gao F, Cao W. The Anti-Breast Cancer Activity of Dihydroartemisinin-5-methylisatin Hybrids Tethered via Different Carbon Spacers. Molecules 2022;27. [PMID: 36432095 DOI: 10.3390/molecules27227994] [Reference Citation Analysis]
5 Zhang S, Yi C, Li WW, Luo Y, Wu YZ, Ling HB. The current scenario on anticancer activity of artemisinin metal complexes, hybrids, and dimers. Arch Pharm (Weinheim) 2022;:e2200086. [PMID: 35484335 DOI: 10.1002/ardp.202200086] [Reference Citation Analysis]